Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer Stock Jumps on Q4 Beats
Merck beats estimates on Q4 earnings, stock slides on tepid 2025 guidance
Merck (MRK) reported fourth quarter and full-year earnings Tuesday, in line with Wall Street estimates. The bad news: Its stock was down more than 10% in early trading, largely because of weaker-than-expected 2025 guidance.
PFE Earnings: Pfizer Stock Jumps on Q4 Beats
Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company’s adjusted EPS of
Pfizer beats Q4, FY '24 earnings estimates, stock down slightly in premarket trading
Pfizer ( PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and sending the stock down about 1% in premarket trading.
Palantir Manages Big Q4 Earnings Beat
Palantir Technologies reported a strong Q4 2024, exceeding both analyst and management expectations, driven by robust U.S. performance.
Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance
We remain confident in our ability to return to pre-pandemic operating margins in the coming years,” said Pfizer CFO David Denton.
Pfizer Stock Rises on Fourth-Quarter Earnings Beat and Reaffirmed Guidance
The CEO said last month that the drugmaker had cut costs, revamped its sales operation, and made other big fixes.
US pharmaceutical giant Pfizer returns to profit in fourth quarter
US pharmaceutical giant Pfizer Inc returned to profit in the fourth quarter from a loss in the same period of the previous year, the company reported on Tuesday, while confirming its outlook for the financial year 2025.
Pfizer (PFE) Beats Q4 Earnings and Revenue Estimates
Pfizer (PFE) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.
3h
on MSN
Insurance broker WTW beats Q4 profit estimates on robust product demand
Insurance broker Willis Towers Watson beat Wall Street estimates for fourth-quarter profit on Tuesday, driven by a strong ...
3h
UBS Earnings: UBS Shares Drop 6% Despite Strong Q4 Profits and Buyback
Shares of the banking giant UBS Group AG (UBS) dropped nearly 6% in pre-market trading, despite reporting strong Q4 profits.
2h
on MSN
Marathon Petroleum: Q4 EPS, Revenue Fall
Marathon Petroleum saw revenue and earnings fall year over year in Q4, leading to a significant profit decline.
2h
Chipotle set to report Q4 earnings as investors look to new CEO, Trump tariffs
Chipotle will have to fight to impress for its Q4 earnings with more headwinds hitting the restaurant industry.
2h
Oakmark U.S. Concentrated Strategy Q4 2024 Commentary
The portfolio’s return was 5.02% (net) for the reporting period vs. S&P 500 Index that returned 2.41% for the same period.
9h
on MSN
Amundi Posts In-Line Q4 Inflows on Risk-Averse Products
Demand for safe investments such as medium and long-term assets through exchange-traded funds and exchange-traded commodities ...
1h
on MSN
Merck Stock Slumps as Q4 Profits, 2025 Forecast Fall Short
Key Takeaways Merck shares fell sharply Tuesday morning after the drugmaker's profits and 2025 outlook fell short of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Tesla
DeepSeek
Merck & Co.
Palantir Technologies
Pfizer
Feedback